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Summary Paragangliomas (glomus tumours) are benign, hypervascular tumours which in general are treated
by surgical excision. The indication for treatment of these often slow-growing tumours needs additional
criteria for predicting tumour progressiveness. For this reason the nuclear DNA content of 99 paragangliomas,
65 of them originating from patients with a positive family history, was analysed by flow cytometry.
Unequivocal evidence of DNA aneuploidy was found in 37% of these clinically and histologically benign
tumours, the average duration of follow up amounting to at least 10 years. The DNA index of the aneuploid
tumours ranged from 0.90 to 2.03. No correlation was found between DNA ploidy and familiality or between
DNA content and clinical criteria indicative of tumour progression, which means that DNA ploidy of these
tumours cannot serve as a predictor for an expected growth pattern or familiality. DNA aneuploidy in
hereditary and sporadic paragangliomas is not clinically related to malignancy, but indicates that these
tumours are true neoplasias cytogenetically.
Paragangliomas (syn.: glomus tumours, chemodectomas) are
rare benign hypervascular tumours originating from the tiny
glomus bodies which are present throughout the body. In the
head and neck area these tumours are mostly found at
specific locations. The most common types, in order of fre-
quency, are the carotid body tumour, the glomus jugulare
tumour, and the vagal body tumour.
Paragangliomas can also present as an autosomal dom-
inant hereditary disease for which, as we showed recently,
genomic imprinting may account for the finding that the
inheritance is almost exclusively via the paternal line (van der
Mey et al., 1989). Familial paragangliomas are often multi-
centric, whether uni- or bilateral (van Gils et al., 1990). The
neoplastic nature of paragangliomas has been a subject of
debate (Chedid & Jao, 1974; Stiller et al., 1975). According
to some authors, carotid body tumours are due to hyper-
plasia. In Peruvians living at high altitudes the glomus bodies
are larger and heavier than in those dwelling at sea level,
possibly due to hyperplasia ofparynchymal tissue in response
to lower P02 levels (Saldana et al., 1973; Arias-Stella &
Valcarcel, 1973). Others believe that the transformation of a
carotid body into a carotid body tumour is due to neoplasia,
because they found residual normal paraganglionic tissue
outside the tumour capsule (Grimley & Glenner, 1967; Lack
et al., 1979).
The morbidity caused by paragangliomas is not related
solely to the highly variable growth pattern, but also to the
mode of treatment applied. Surgical excision, where feasible,
is considered to be the treatment of choice (Rosenwasser,
1973; Brackmann, 1988). For the glomus jugulare tumours
invading the skull base and sometimes the posterior and
middle fossa such surgical resection is a major intervention,
frequently resulting in considerable and permanent cranial
nerve palsy.
In general, the growth pattern of these neuro-endocrine
tumours is characterised by extremely slow progression and
in such cases it is difficult to decide whether to perform
extensive tumour resection. Sometimes, however, the tumour
develops rapidly threatening a number of functions or even
the life of the patient.
With respect to both sporadic and familial paragan-
gliomas, there is an urgent need of information about the
growth kinetics, for definition of the indication, but also for
the timing of surgical treatment. Such information is not
provided by the histological features of the tumour (Lack et
al., 1979).
Flow cytometric analysis of the DNA content has revealed
the widespread occurrence of DNA ploidy changes in human
malignancies (Koss et al., 1989; Cornelisse & Tanke, 1990).
Evidence pointing to an association between DNA aneu-
ploidy and clinical aggressiveness in various types of solid
tumour has been accumulating (Merkel & McGuire, 1990).
The aim of the present study was to find out whether DNA
aneuploidy could be detected in paragangliomas as support
for a neoplastic origin and, if so, whether this DNA aneu-
ploidy is associated with the clinical extension of the tumour
and can be used as a predictor of the growth rate. Further-
more, we were interested in finding out whether there were
differences in DNA ploidy distribution between familial and
sporadic tumours on the one hand and the ploidy distribu-
tion of multicentric tumours within the same patient or
family on the other. The results indicate that DNA aneuplo-
idy occurs relatively frequently in both familial and sporadic
paragangliomas, but no correlations with clinical extension
were found.
Materials and methods
Patients
During the past 32 years (1956-1988), the diagnosis para-
ganglioma was made in 108 patients (male:female = 44:64),
referred to the departments of Otolaryngology and Surgery
of the Leiden University Hospital. A positive family history
was found in 58 cases (53%). These 108 patients accounted
for a total of 173 paragangliomas, i.e., 50 glomus jugulotym-
panic tumours (GJTT), 32 vagal body tumours (VBT), and
91 carotid body tumours (CBT). The diagnosis was histo-
logically confirmed in almost all of the 132 excised tumours.
Tissue blocks cut from 132 paragangliomas were available
for DNA flow cytometry (FCM). This study was limited to
99 tumours providing sufficient material to permit conclusive
interpretation of the DNA profile (obtained from 77 patients,
47 of whom had a positive family history). Prior to surgical
removal none of the tumours had been irradiated.
All histological slides were reviewed by two of the authors
(A.G.M., G.J.F.) according to the established histological
criteria for paragangliomas. One of the main characteristics
of paragangliomas is the presence of clusters of tumour cells
(Zellballen) interspersed among an extensive capillary net-
work. This Zellballen pattern is demonstrated best by silver
Correspondence: A.G.L. van der Mey, Department of Otolaryn-
gology, Leiden University Hospital, PO Box 9600, 2300 RC Leiden,
The Netherlands.
Received 6 July 1990; and in revised form 13 September 1990.
Br. J. Cancer (1991), 63, 298-302 '." Macmillan Press Ltd., 1991DNA FLOW CYTOMETRY OF PARAGANGLIOMAS 299
impregnation of the reticulin fibres (Lack et al., 1979; Bat-
sakis, 1982). No histological or clinical evidence of distant
metastases was found in any of these 99 tumours (77 pa-
tients).
The clinical data were retrieved from the status reports and
in most cases supplied information on the following items:
family history of paragangliomas; tumour localisation
(GJTT, VBT, CBT), and data providing an indication about
the extension of the tumour and the rate of growth, e.g. the
age at first diagnosis, duration of symptoms, and the size of
the tumour.
For 20 skull-base tumours (GJTT), the tumour size and
FCM were available. According to Rosenwasser (1973), three
size classes can be recognised: Small tumours: tumour
confined to the middle ear space without extension or tumour
in the hypotympanum, usually a glomus tympanic tumour
that arises on the promontory or the floor of the tympanum
(n = 6); tumours of intermediate size: the tumour has pene-
trated beyond the middle ear in the direction of the mastoid
and with involvement of the hypotympanum, indicating that
the process originated in the jugular bulb (n = 3); and large
tumours: the tumour shows wide spread extension into the
base of the skull or intracranially (n = 11).
The volume of the vagal and carotid body tumours
(n = 74) was calculated from the dimensions given in the
histopathological report. Tumour volumes ranged from I cm3
to 224 cm3. Since no established or uniform size classification
was available (before and after introduction of the CT scan)
for paragangliomas, we arbitrarily subdivided tumour vol-
ume into another three size classes each of which covered
approximately one-third of the cases. Tumours measuring
between and 18 cm3 (n = 33) were called small; those
between 18 to 60 cm3 intermediate (n = 32), and those of
60 cm3 or larger (n = 9). In all, 39 tumours were classified as
small, 35 as intermediate, and 20 as large. For five tumours
no size had been recorded.
Flow cytometry
The procedures used for cell preparation and the staining of
fresh and paraffin-embedded tissue have been described else-
where (Cornelisse et al., 1987). Briefly, suspensions of isolat-
ed nuclei were prepared from fresh or frozen tissue specimens
according to the detergent-trypsin procedure and stained with
propidium iodide (PI) (Vindelov et al., 1983). Rainbow trout
red blood cells (TRBC) were added to the suspensions of
isolated nuclei prepared from fresh or frozen samples as an
internal ploidy standard. Frozen and paraffin sections of each
tissue block were examined to see whether there was an
adequate proportion (> 10%) of tumour cells. The pepsin-
digestion technique was used to release nuclei from
40-50lim sections of paraffin-embedded tumour specimens
according to Hedly et al. (1983) with some minor
modifications (Rodenburg et al., 1987). Deparaffinised sam-
ples were stained with DAPI (4',6,-diamidino-2-phenylindol;
ICP-22 flow cytometer) or PI (FACSCAN flow cytometer).
Measurements were made initially with an ICP-22 flow
cytometer and later with an FACSCAN flow cytometer (Bec-
ton and Dickinson, Mountain View, CA, USA) with use of
the appropriate filter combinations for the excitation of
DAPI and PI fluorescence, respectively. DNA profiles pro-
duced by the two instruments had a similar resolution and
did not show systematic differences. DNA profiles showing
only a single GO/GI peak were classified as DNA diploid. The
position of the diploid peak in DNA profiles from fresh or
frozen samples was verified with aid of the TRBC standard.
For DNA profiles from deparaffined samples the most left
Go/GI peak was considered to represent the diploid popula-
tion. Single GO/GI peaks with a coefficient of variation (CV)
of >5.5, were classified as peridiploid, and DNA profiles
showing two or more GO/GI peaks as aneuploid. The peridip-
loid group may thus contain both tumours from which the
high CV has obscured the presence of a near-diploid, aneu-
ploid DNA stemline as well as 'true' DNA-diploid tumours
which yield broad GO/GI peaks because of e.g, suboptimal
fixation of the paraffin embedded tissue (Rodeburg et al.,
1987). The overall median CV was 5.7, whereas the median
CV for the diploid GO/GI population in aneuploid tumours
was 4.5. We consider the latter the better estimate for the
quality of the measurements since these consist of normal cell
populations. There were eight fresh and 91 paraffin embed-
ded samples. In several cases, DNA profiles showing a single
GO/G1 peak with an enlarged G2M peak were observed.
However, no second G2M fraction was seen at twice the
modal channel number of the first (enlarged) G2M fraction.
Because of the uncertainty as to whether these profiles
indicated the presence of a true tetraploid DNA stemline,
they were classified as peridiploid with enlarged G2M, and
due to the variable quality of the DNA profiles derived from
deparaffinized tumours samples, no attempt was made to
calculate S-phase fractions.
Statistics
Differences between tumour groups in frequency tables and
cross tables were evaluated by the t-test, analysis of variance,
and the chi-square test.
Results
Of the 99 tumours, 14 were DNA diploid, 33 peridiploid, and
37 aneuploid. Among the DNA aneuploid tumours, only two
had multiple aneuploid DNA stemlines. Fifteen tumours
showed a peridiploid DNA profile with an enlarged G2M
fraction. For the statistical analysis used to detect correla-
tions between DNA ploidy and clinical features, DNA di-
ploid and peridiploid cases were grouped together into one
near-diploid class. The distribution of the ploidy classes in
the familial and non-familial groups is shown in Table Ia.
The frequency distribution of DNA indices shows scattering
between the diploid and tetraploid ranges (Figure 1). Apart
from the fact that more familial tumours were measured,
there was no significant different in DNA index distribution
between the familial and non-familial cases.
Individual patients belonging to the same family, showed
no tendency to similarity in DNA ploidy pattern. Multicen-
tricity was found predominantly in the familial group of 47
patients, 16 of whom had a double tumour (uni- or bilateral)
and one even had three tumours. In the non-familial group
(n = 30) only four patients had a double tumour. The DNA
ploidy distribution in double tumours (Table II) showed that
both tumours were DNA diploid or peridiploid in ten pa-
tients and that in three out of five patients with DNA
Table I Results of DNA flow cytometry
A ND (Di) PD + G2+ AN Total
Fam 33 (10) 10 22 65
Non Fam 14 (4) 5 15 34
Total 47 (14) 15 37 99
B ND (Di) PD + GSt AN Total
GJTT 16 (2) 1 3 20
VBT 5 (3) 2 7 14
CBT 26 (9) 12 27 65
Total 47 (14) 15 37 99
C ND PD + G2+ AN
mean 36 42 39 Age s.d. 13 8 14
Duration of median 3 4.5 2
symptoms (min.max) (1.35) (1.20) (1.10)
Abbreviations: ND = Near-Diploid; Di = Diploid; AN = Aneu-
ploid; PD + G2+ = Peridiploid with elevated G2M fraction. a,
Distribution of 99 tumours with respect to familial and non-familial
cases. b, Tumour localisation for 99 tumours (GJTT, VBT, CBT -
for explanation see the text). c, Age at onset of disease (77 patients)
and duration of symptoms (73 patients), both given in years.300 A.G.L. VAN DER MEY et al.
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Figure 1 DNA index frequency for familial and non familial
paragangliomas (n = 99).
Table II DNA indices of tumours in patients with multiple
tumours. Note that the cases are grouped by ploidy class.
Case No DI (Ti) DI (T2) DI (T3)
Diploid
Peridiploid
Aneuploid
085
095
099
106
015
023
028
029
097
100
017*
048*
107*
055
098
004
016
038
044
075
096
Mixed
1.00
1.00
1.00
1.00
± 1.0
± 1.0
± 1.0
± 1.0
± 1.0
± 1.0
1.80
0.90/1.85
1.18
1.61
1.69
1.82
1.00
1.42
1.00
± 1.0
± 1.0
1.00
1.00
1.00
1.00
± 1.0
± 1.0
± 1.0
± 1.0
± 1.0
± 1.0
1.95
1.79
1.19
1.10
1.16
± 1.0
1.58
1.00
1.66
1.65
1.75
± 1.0
DI = DNA index; TI, T2, T3 = Number of tumours.
aneuploid tumours, both tumours had almost identical DNA
indices. For case no. 48, the second stemline of tumour TI,
which DNA index of 1.85 is nearly similar to that of the
contralateral tumour T2 (DNA index = 1.79) probably arose
via polyploidisation of the first, hypodiploid stemline (DNA
index = 0.90). However, this hypodiploid stemline is not pre-
sent in tumour T2 (Figure 2). In the remaining patients the
DNA stemlines of double tumours differed significantly.
DNA ploidy and clinical characteristics
After subdivision according to tumour localisation in the
head and neck (i.e. GJTT, VBT, CBT), no correlation was
found between DNA ploidy and these localisations (Table
Ib).
The average age at first diagnosis was available for 77
patients and was somewhat lower for the familial group, but
this difference was not statistically significant. A correlation
between DNA ploidy and the age at first diagnosis was not
found. The mean age of the patients with DNA diploid
tumours was 36 years and that of the peridiploid with
elevated G2M phase and DNA aneuploid stemlines was 42
and 39 years, respectively (Table Ic).
The average duration of symptoms was known for 73
patients. For the duration of symptoms there was a remark-
able great difference between the minimum and maximum
number of years recorded (Table Ic). Irrespective of ploidy
class, the average duration of symptoms amounted to about
3 years.
For 94 paragangliomas, DNA ploidy was analysed in rela-
tion to tumour size. However, the DNA ploidy distribution
for small, intermediate, and large tumours did not differ
significantly. When familial clustering was taken into account
with respect to the average age at diagnosis, the duration of
symptoms, and the size of the tumour, no significant
differences were found.
Discussion
The results of this study show that aneuploid stemlines occur
relatively frequently in clinically and histologically benign
paragangliomas (37%), indicating that cytogenetically, these
tumours represent true clonal proliferations. Although no
definite proof, this strongly supports the neoplastic rather
than the hyperplastic nature of these lesions as argued by
some authors (Saldana et al., 1973; Arias-Stella & Valcarcel,
1973). Similar results have recently been reported for a series
of 13 carotid body tumours analysed with DNA-image cyto-
metry by Barnes & Taylor (1990) who found abnormal
DNA-histograms in 69% of the cases of which 15% were
true aneuploid.
DNA aneuploidy has also been described for other benign
tumours of neuro-endocrine origin. In a flow-cytometric
study of pituitary adenomas done by Anniko et al. (1984),
aneuploidy was found in 49% of the cases, and Joensuu &
Klemi (1988) reported aneuploidy for 29% of pituitary, 25%
of thyroid, 26% of parathyroid, and 53% of adrenal aden-
omas without sign ofinvasive growth. Others have confirmed
their findings (Joensuu & Klemi, 1988, references cited there-
in, Schelfhout et al., 1990). Thus, unlike colorectal adenomas,
DNA aneuploidy in neuro-endocrine adenomas appears not
be associated with a premalignant condition (van den Ingh et
al., 1985).
A correlation between DNA aneuploidy and the age of the
patients with paragangliomas similar to that described by
Joensuu & Klemi (1988) for other benign endocrine tumours
was not found in the present study.
DNA ploidy distribution was not associated with familial
clustering of the disease, which suggests that tumour-ploidy
evolution did not differ essentially between the two categories
of patients. In 13/21 (62%) of the patients with a double
tumour, the two lesions had similar, predominantly (peri-)
diploid, DNA indices (Table II). With respect to the rela-
tively low prevalence of DNA aneuploidy, the a priori proba-
bility ofa combination of two (peri-)diploid stemlines is high.
However, the observation that three out of five double
tumours with DNA-aneuploid stemlines had closely similar
DNA indices at first sight seems more puzzling. In one case
(no. 107), the confluence of two tumour sites cannot be ex-
cluded. This does not hold for the other two patients
(nos. 017, 048) who had bilateral tumours. In case no. 048
there is only a partial agreement since the hypodiploid stem-
line is lacking in the T2 tumour. Therefore, there is not
enough evidence to suggest a non-random ploidy evolution
of multicentric tumours in patients with hereditary disease
even when a common, predisposing genetic condition can be
assumed to be present. Such a 'programmed' ploidy evolu-
tion process, leading to identical karyotypes with the same
specific and non-specific (secondary) chromosomal aberra-
tions and hence identical DNA contents, would be at vari-
ance with the concepts on the stochastic nature of DNA
ploidy evolution (van den Ingh et al., 1985; Schwartz et al.,
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Figure 2 DNA profiles of two carotid body tumours (CBTs) in a single patient (viz, case no. 048).
CBT right-sided T1 - without TRBC-standard; CBT left-sided T2 ->* without TRBC-standard;
Tj* +with TRBC-standard; T*-*- with TRBC-standard.
1986, Sciallero et al., 1988; Shackney et al., 1989; Smit et al.,
1990).
The relatively high proportion (15%) of peridiploid tu-
mours with elevated G2M fraction compares with the 23%
diploid-tetraploid tumours found in the series of Barnes and
Taylor (1990). This probably indicates a tendency of para-
gangliomas to develop genetically relatively stable tetraploid
subpopulations which do not or only slowly progress to overt
aneuploidy by chromosome loss.
Unlike the situation for several malignant tumours, no
relationship was found between DNA ploidy and clinical
signs of tumour progression.
Since the life expectancy of patients with paragangliomas
does not differ significantly from that of the general popula-
tion, we attempted to express tumour progression on the
basis of parameters such as age at diagnosis, duration of
symptoms, and size of the tumour. Since the introduction of
CT scanning during the late seventies, it has been possible to
make accurate and standardised estimations of tumour exten-
sion. In our retrospective study covering a period of 32 years,
CT scans were not available for all of the patients and
therefore paraganglioma size had to be classified semi-quanti-
tatively, i.e. less objectively, particularly for skull-base
tumours.
The absence of correlation between DNA ploidy and
clinical signs of tumour progression indicates that at least at
present, analysis of the DNA content is of no help in
reaching a clinical decision as to whether or not extensive
surgery should be performed in cases of young patients with
paragangliomas. A similar conclusion was reached by Barnes
and Taylor (1990).
It remains an intriguing problem, that a variety of tumours
of neuro-endocrine origin, including paragangliomas, can
develop a quite pronounced DNA aneuploidy, that is indica-
tive of numerical and probably also structural chromosomal
aberrations, without showing overt signs of clinical malig-
nancy. Recently, the presence of somatostatin receptors have
been demonstrated in paragangliomas (Pauw et al., 1989).
The presence of these receptors in other neuro-endocrine
tumours and breast tumours with neuro-endocrine charac-
teristics appear to be associated with a differentiated type of
tumour with rather low malignancy (Reubi & Torhorst, 1989,
references cited therein). One could hypothesise that the high
somatostatin receptor content of paragangliomas may have
some relationship with their usually indolent biological be-
haviour.
Lastly, our results show that in contrast with the situation
for colorectal adenomas (Sciallero et al., 1988), genetic pre-
disposition does not lead to a higher incidence or more
extensive development of aneuploidy in paragangliomas.
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